600056 中国医药
已收盘 08-16 15:00:00
资讯
新帖
简况
猴痘概念盘中跳水，中国医药跌0.48%
自选股智能写手 · 09:38
猴痘概念盘中跳水，中国医药跌0.48%
医药商业行业盘中跳水，中国医药跌0.48%
自选股智能写手 · 08-14 09:37
医药商业行业盘中跳水，中国医药跌0.48%
中国医药最新公告：盐酸达泊西汀获得化学原料药上市申请批准通知书
证券之星 · 08-12
中国医药最新公告：盐酸达泊西汀获得化学原料药上市申请批准通知书
中国医药(600056.SH)：盐酸达泊西汀获化学原料药上市申请批准通知书
智通财经 · 08-12
中国医药(600056.SH)：盐酸达泊西汀获化学原料药上市申请批准通知书
【中国医药：子公司天方药业获盐酸达泊西汀化学原料药上市批准】金十数据8月12日讯，中国医药公告，下属全资子公司天方药业收到国家药监局核准签发的盐酸达泊西汀化学原料药上市申请批准通知书，表明原料药符合国内药品注册要求，可在国内上市制剂中使用。
美港电讯 · 08-12
【中国医药：子公司天方药业获盐酸达泊西汀化学原料药上市批准】金十数据8月12日讯，中国医药公告，下属全资子公司天方药业收到国家药监局核准签发的盐酸达泊西汀化学原料药上市申请批准通知书，表明原料药符合国内药品注册要求，可在国内上市制剂中使用。
睿智投资｜中国医药 - 反弹趋势基本确定，业绩有望复苏
招银国际 · 08-12
睿智投资｜中国医药 - 反弹趋势基本确定，业绩有望复苏
中国医药(600056.SH)：注射用头孢呋辛钠通过仿制药一致性评价
智通财经 · 08-08
中国医药(600056.SH)：注射用头孢呋辛钠通过仿制药一致性评价
中国医药(600056.SH)：注射用头孢呋辛钠获得药品补充申请批准通知书
格隆汇资讯 · 08-08
中国医药(600056.SH)：注射用头孢呋辛钠获得药品补充申请批准通知书
中国医药：子公司药品申请获批
财通社 · 08-08
中国医药：子公司药品申请获批
北向资金8月7日净买入中国医药20.97万股 连续7日增持
自选股智能写手 · 08-08
北向资金8月7日净买入中国医药20.97万股 连续7日增持
中国医药： 截至2024年3月31日，公司普通股股东总数为168,356
证券之星 · 08-06
中国医药： 截至2024年3月31日，公司普通股股东总数为168,356
北向资金8月5日净买入中国医药21.40万股 连续5日增持
自选股智能写手 · 08-06
北向资金8月5日净买入中国医药21.40万股 连续5日增持
北向资金8月1日净买入中国医药6.90万股 连续3日增持
自选股智能写手 · 08-02
北向资金8月1日净买入中国医药6.90万股 连续3日增持
中国医药07月29日遭主力抛售665万元 环比增加939.06%
自选股智能写手 · 07-29
中国医药07月29日遭主力抛售665万元 环比增加939.06%
北向资金7月26日净买入中国医药49.43万股 连续3日增持
自选股智能写手 · 07-29
北向资金7月26日净买入中国医药49.43万股 连续3日增持
中国医药07月26日主力资金流出64万元 连续3日减仓
自选股智能写手 · 07-26
中国医药07月26日主力资金流出64万元 连续3日减仓
天眼查App显示近日中国医药集团有限公司发生工商变更刘敬桢卸任法定代表人、董事长由白忠泉接任同时多位主要人员也发生变更。中国医药集团有限公司成立于1987年3月注册资本约255.
智通财经 · 07-23
天眼查App显示近日中国医药集团有限公司发生工商变更刘敬桢卸任法定代表人、董事长由白忠泉接任同时多位主要人员也发生变更。中国医药集团有限公司成立于1987年3月注册资本约255.
北向资金7月19日净买入中国医药7.46万股 连续3日增持
自选股智能写手 · 07-22
北向资金7月19日净买入中国医药7.46万股 连续3日增持
中国医药(600056.SH)：通用技术集团拟收购重庆医药相关股权
格隆汇资讯 · 07-18
中国医药(600056.SH)：通用技术集团拟收购重庆医药相关股权
血液制品概念盘中跳水，同方股份跌1.00%
自选股智能写手 · 07-15
血液制品概念盘中跳水，同方股份跌1.00%
暂无数据
公司概况
公司名称：
中国医药健康产业股份有限公司
所属行业：
批发业
上市日期：
1997-05-15
主营业务：
中国医药健康产业股份有限公司建立了以国际贸易为引领、以医药工业为支撑、以医药商业为纽带的贸、工、技、服一体化产业格局，全面推动工商贸三大业务板块业务整合，积极发挥协同优势。主要产品有原料药、制剂药、中成药、医药商业、国际贸易。公司在中国物流与采购联合会医疗器械供应链分会发布的“2023年中国医疗器械供应链百强企业”中位列第5位；在“2023年中国医疗器械SPD运营服务商重点企业”中位列第11位。
发行价格：
7.02
{"stockData":{"symbol":"600056","market":"SH","secType":"STK","nameCN":"中国医药","latestPrice":10.53,"timestamp":1723791600000,"preClose":10.46,"halted":0,"volume":9478591,"delay":0,"floatShares":1495000000,"shares":1496000000,"eps":0.6183,"marketStatus":"已收盘","marketStatusCode":5,"change":0.07,"latestTime":"08-16 15:00:00","open":10.39,"high":10.54,"low":10.36,"amount":99118100,"amplitude":0.0172,"askPrice":10.53,"askSize":218,"bidPrice":10.52,"bidSize":372,"shortable":0,"etf":0,"ttmEps":0.6183,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1724031000000},"adr":0,"adjPreClose":10.46,"symbolType":"stock","openAndCloseTimeList":[[1723771800000,1723779000000],[1723784400000,1723791600000]],"highLimit":11.51,"lowLimit":9.41,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":1495879748,"pbRate":1.35,"roa":"--","roe":"1.34%","epsLYR":0.7006,"committee":-0.300536,"marketValue":15752000000,"floatMarketCap":15746000000,"peRate":17.030567,"changeRate":0.0067,"turnoverRate":0.0063,"status":0},"requestUrl":"/m/hq/s/600056/tweets","defaultTab":"tweets","newsList":[{"id":"2459395192","title":"猴痘概念盘中跳水，中国医药跌0.48%","url":"https://stock-news.laohu8.com/highlight/detail?id=2459395192","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459395192?lang=zh_cn&edition=full","pubTime":"2024-08-16 09:38","pubTimestamp":1723772334,"startTime":"0","endTime":"0","summary":"08月16日，猴痘概念盘中跳水，截至09点38分，猴痘概念整体指数下跌0.61%，报775.940点。从个股上来看，该概念的成分股中，中国医药跌0.48%，新产业、圣湘生物、硕世生物跌幅居前。从资金上来看，截止发稿，猴痘概念主力净流入为-7485.73万，其中凯普生物受到资金热捧，主力净流入1050.30万；拉长时间线来看，该板块近20日主力资金净流入-10.26亿。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240816093854af977aae&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240816093854af977aae&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["600056","BK0028","BK0185","BK0082","BK0010","BK0188","BK0175","BK0250"],"gpt_icon":0},{"id":"2459621681","title":"医药商业行业盘中跳水，中国医药跌0.48%","url":"https://stock-news.laohu8.com/highlight/detail?id=2459621681","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459621681?lang=zh_cn&edition=full","pubTime":"2024-08-14 09:37","pubTimestamp":1723599442,"startTime":"0","endTime":"0","summary":"08月14日，医药商业行业盘中跳水，截至09点37分，医药商业行业整体指数下跌1.01%，报4524.130点。从个股上来看，该行业的成分股中，中国医药跌0.48%，第一医药、重药控股、人民同泰跌幅居前。从资金上来看，截止发稿，医药商业行业主力净流入为-1350.32万，其中国药一致受到资金热捧，主力净流入133.60万；拉长时间线来看，该板块近20日主力资金净流入-1.00亿。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240814093722aefeaea3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240814093722aefeaea3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0175","BK0082","BK0028","600056","BK0188","BK0010","BK0185","BK0250","159938"],"gpt_icon":0},{"id":"2458672314","title":"中国医药最新公告：盐酸达泊西汀获得化学原料药上市申请批准通知书","url":"https://stock-news.laohu8.com/highlight/detail?id=2458672314","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458672314?lang=zh_cn&edition=full","pubTime":"2024-08-12 17:20","pubTimestamp":1723454400,"startTime":"0","endTime":"0","summary":"中国医药公告，下属全资子公司天方药业有限公司收到国家药品监督管理局核准签发的盐酸达泊西汀《化学原料药上市申请批准通知书》。该药品适用于治疗18至64岁男性早泄（PE）患者。以上内容由证券之星根据公开信息整理，由算法生成（网信算备310104345710301240019号），与本站立场无关，如数据存在问题请联系我们。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024081200023605.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0175","BK0082","BK0188","BK0185","600056","BK0010","BK0250","BK0028"],"gpt_icon":0},{"id":"2458671740","title":"中国医药(600056.SH)：盐酸达泊西汀获化学原料药上市申请批准通知书","url":"https://stock-news.laohu8.com/highlight/detail?id=2458671740","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458671740?lang=zh_cn&edition=full","pubTime":"2024-08-12 17:12","pubTimestamp":1723453967,"startTime":"0","endTime":"0","summary":"智通财经APP讯，中国医药(600056.SH)公告，近日，公司下属全资子公司天方药业有限公司(简称“天方药业”)收到国家药品监督管理局(简称“国家药监局”)核准签发的盐酸达泊西汀《化学原料药上市申请批准通知书》。据悉，该药品适用于治疗18至64岁男性早泄(PE)患者。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1162970.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0028","BK0185","600056","BK0175","BK0188","BK0082","BK0010","BK0250"],"gpt_icon":0},{"id":"2458671614","title":"【中国医药：子公司天方药业获盐酸达泊西汀化学原料药上市批准】金十数据8月12日讯，中国医药公告，下属全资子公司天方药业收到国家药监局核准签发的盐酸达泊西汀化学原料药上市申请批准通知书，表明原料药符合国内药品注册要求，可在国内上市制剂中使用。","url":"https://stock-news.laohu8.com/highlight/detail?id=2458671614","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458671614?lang=zh_cn&edition=full","pubTime":"2024-08-12 17:08","pubTimestamp":1723453719,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["BK0028","BK0082","600056","BK0010","BK0188","BK0250","BK0175","BK0185"],"gpt_icon":0},{"id":"2458264710","title":"睿智投资｜中国医药 - 反弹趋势基本确定，业绩有望复苏","url":"https://stock-news.laohu8.com/highlight/detail?id=2458264710","media":"招银国际","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458264710?lang=zh_cn&edition=full","pubTime":"2024-08-12 11:27","pubTimestamp":1723433243,"startTime":"0","endTime":"0","summary":"DRG/DIP 2.0版本发布，继续给予创新药械政策支持，加快医保资金结算。DRG/DIP政策持续支持创新药耗的报销。此外，文件提到“探索除外机制，对符合条件的新药耗新技术在应用初期按项目付费或以权重（点数）加成等方式予以支持，后期积累足够数据后再纳入DRG/DIP付费。”看好医药行业反弹，主要由于1）医疗设备更新政策刺激采购需求，创新药械支持政策陆续落地；2）出海提供增长动力；3）常态化监管环境下企业盈利复苏。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081211290195913875&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081211290195913875&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0010","BK0185","BK0250","BK0082","BK0188","BK0028","600056","BK0175"],"gpt_icon":0},{"id":"2457366607","title":"中国医药(600056.SH)：注射用头孢呋辛钠通过仿制药一致性评价","url":"https://stock-news.laohu8.com/highlight/detail?id=2457366607","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457366607?lang=zh_cn&edition=full","pubTime":"2024-08-08 16:55","pubTimestamp":1723107306,"startTime":"0","endTime":"0","summary":"智通财经APP讯，中国医药(600056.SH)发布公告，公司下属全资子公司海南通用三洋药业有限公司(简称“三洋药业”)收到国家药品监督管理局核准签发的五份注射用头孢呋辛钠《药品补充申请批准通知书》，该药品通过仿制药质量和疗效一致性评价。据悉，注射用头孢呋辛钠最早是由英国葛兰素公司研制开发，为第二代头孢菌素类抗生素，具有广谱抗菌作用，适用范围广，可用于由特定微生物敏感菌株引起的感染：呼吸道感染、耳鼻喉感染、泌尿系感染、皮肤和软组织感染、败血症、脑膜炎、淋病、骨和关节感染、产褥期和妇科感染等。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1161630.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0175","BK0188","BK0250","BK0082","BK0010","BK0185","BK0028","600056"],"gpt_icon":0},{"id":"2457662533","title":"中国医药(600056.SH)：注射用头孢呋辛钠获得药品补充申请批准通知书","url":"https://stock-news.laohu8.com/highlight/detail?id=2457662533","media":"格隆汇资讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457662533?lang=zh_cn&edition=full","pubTime":"2024-08-08 16:48","pubTimestamp":1723106918,"startTime":"0","endTime":"0","summary":"格隆汇8月8日丨中国医药(600056.SH)公布，下属全资子公司海南通用三洋药业有限公司收到国家药品监督管理局核准签发的五份注射用头孢呋辛钠《药品补充申请批准通知书》，该药品通过仿制药质量和疗效一致性评价。注射用头孢呋辛钠最早是由英国葛兰素公司研制开发，为第二代头孢菌素类抗生素，具有广谱抗菌作用，适用范围广，可用于由特定微生物敏感菌株引起的感染：呼吸道感染、耳鼻喉感染、泌尿系感染、皮肤和软组织感染、败血症、脑膜炎、淋病、骨和关节感染、产褥期和妇科感染等。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024080816484595884f32&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024080816484595884f32&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0028","600056","BK0175","BK0010","BK0188","BK0250","BK0082","BK0185"],"gpt_icon":0},{"id":"2457654413","title":"中国医药：子公司药品申请获批","url":"https://stock-news.laohu8.com/highlight/detail?id=2457654413","media":"财通社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457654413?lang=zh_cn&edition=full","pubTime":"2024-08-08 16:46","pubTimestamp":1723106760,"startTime":"0","endTime":"0","summary":"中国医药公告，公司全资子公司海南通用三洋药业有限公司收到国家药监局核准签发的五份注射用头孢呋辛钠《药品补充申请批准通知书》，该药品通过仿制药质量和疗效一致性评价。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024080816470995884e2c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024080816470995884e2c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0028","BK0250","600056","BK0082","BK0010","BK0185","BK0188","BK0175"],"gpt_icon":0},{"id":"2457650389","title":"北向资金8月7日净买入中国医药20.97万股 连续7日增持","url":"https://stock-news.laohu8.com/highlight/detail?id=2457650389","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457650389?lang=zh_cn&edition=full","pubTime":"2024-08-08 09:30","pubTimestamp":1723080607,"startTime":"0","endTime":"0","summary":"8月7日, 北向资金增持中国医药20.97万股，连续7日增持。截止当日收盘，沪股通共持有中国医药1794.34万股，占流通股1.19%。沪股通增持金额前五个股分别为贵州茅台、福斯特、通威股份、恒瑞医药、金龙汽车。中国医药近5个交易日上涨1.55%，沪股通累计增持90.48万股；近20个交易日上涨5.42%，沪股通累计增持226.52万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408080930199f18bcae&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408080930199f18bcae&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0028","BK0082","600056","BK0010","BK0175","BK0188","BK0185","BK0250"],"gpt_icon":0},{"id":"2457017903","title":"中国医药：\n截至2024年3月31日，公司普通股股东总数为168,356","url":"https://stock-news.laohu8.com/highlight/detail?id=2457017903","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457017903?lang=zh_cn&edition=full","pubTime":"2024-08-06 19:01","pubTimestamp":1722942063,"startTime":"0","endTime":"0","summary":"证券之星消息，中国医药(600056)08月06日在投资者关系平台上答复投资者关心的问题。投资者：董秘你好，截止8/5/日收盘，中国医药在册股东人数是多少？中国医药董秘：尊敬的投资者您好，截至2024年3月31日，公司普通股股东总数为168,356。感谢您对公司的关注。以上内容由证券之星根据公开信息整理，由算法生成（网信算备310104345710301240019号），与本站立场无关，如数据存在问题请联系我们。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024080600036609.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0010","BK0082","BK0175","BK0028","BK0185","BK0188","BK0250","600056"],"gpt_icon":0},{"id":"2457037577","title":"北向资金8月5日净买入中国医药21.40万股 连续5日增持","url":"https://stock-news.laohu8.com/highlight/detail?id=2457037577","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457037577?lang=zh_cn&edition=full","pubTime":"2024-08-06 09:30","pubTimestamp":1722907807,"startTime":"0","endTime":"0","summary":"8月5日, 北向资金增持中国医药21.40万股，连续5日增持。截止当日收盘，沪股通共持有中国医药1751.62万股，占流通股1.17%。沪股通增持金额前五个股分别为贵州茅台、紫金矿业、长电科技、中国石油、澜起科技。中国医药近5个交易日上涨3.07%，沪股通累计增持128.42万股；近20个交易日上涨4.51%，沪股通累计增持154.65万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408060930269580a042&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408060930269580a042&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0185","BK0028","BK0010","BK0175","BK0250","BK0188","BK0082","600056"],"gpt_icon":0},{"id":"2456741636","title":"北向资金8月1日净买入中国医药6.90万股 连续3日增持","url":"https://stock-news.laohu8.com/highlight/detail?id=2456741636","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456741636?lang=zh_cn&edition=full","pubTime":"2024-08-02 09:30","pubTimestamp":1722562205,"startTime":"0","endTime":"0","summary":"8月1日, 北向资金增持中国医药6.90万股，连续3日增持。截止当日收盘，沪股通共持有中国医药1710.76万股，占流通股1.14%。沪股通增持金额前五个股分别为药明康德、中国中车、中国核电、中信证券、农业银行。中国医药近5个交易日上涨1.78%，沪股通累计增持116.20万股；近20个交易日上涨2.39%，沪股通累计增持179.23万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024080209302095761f54&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024080209302095761f54&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0077","000159","BK0019","BK0175","BK0188","BK0250","BK0029","BK0082","BK0010","BK0185","BK0028","600056","BK0025"],"gpt_icon":0},{"id":"2455684097","title":"中国医药07月29日遭主力抛售665万元 环比增加939.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2455684097","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455684097?lang=zh_cn&edition=full","pubTime":"2024-07-29 15:17","pubTimestamp":1722237454,"startTime":"0","endTime":"0","summary":"07月29日, 中国医药股价跌0.59%，报收10.11元，成交金额4616万元，换手率0.30%，振幅0.69%，量比0.75。中国医药今日主力资金净流出665万元，连续4日净流出，上一交易日主力净流出64万元，今日环比增加939.06%。该股近5个交易日下跌1.27%，主力资金累计净流出599万元，其中2个交易日为股价上涨时净流出；近20日主力资金累计净流出5487万元，其中净流出天数为16日。净流出前三个股分别为中国医药、国药一致、大参林。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407291519429565335b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407291519429565335b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0175","BK0082","BK0028","600056","BK0188","BK0010","BK0185","BK0250"],"gpt_icon":0},{"id":"2455508525","title":"北向资金7月26日净买入中国医药49.43万股 连续3日增持","url":"https://stock-news.laohu8.com/highlight/detail?id=2455508525","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455508525?lang=zh_cn&edition=full","pubTime":"2024-07-29 09:30","pubTimestamp":1722216606,"startTime":"0","endTime":"0","summary":"7月26日, 北向资金增持中国医药49.43万股，连续3日增持。截止当日收盘，沪股通共持有中国医药1644.00万股，占流通股1.09%。沪股通增持金额前五个股分别为海尔智家、长江电力、寒武纪-U、中国船舶、京沪高铁。中国医药近5个交易日上涨0.10%，沪股通累计增持34.93万股；近20个交易日上涨0.49%，沪股通累计增持120.72万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407290930199563fd86&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407290930199563fd86&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0185","BK0028","BK0188","600056","BK0010","BK0250","BK0082","BK0175"],"gpt_icon":0},{"id":"2454911613","title":"中国医药07月26日主力资金流出64万元 连续3日减仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2454911613","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2454911613?lang=zh_cn&edition=full","pubTime":"2024-07-26 15:17","pubTimestamp":1721978272,"startTime":"0","endTime":"0","summary":"07月26日, 中国医药股价涨0.59%，报收10.17元，成交金额5190万元，换手率0.34%，振幅1.19%，量比0.84。中国医药今日主力资金净流出64万元，连续3日净流出，上一交易日主力净流出270万元，今日环比减少76.30%。近一年数据显示，该股主力连续3日净流出后，次日下跌概率为47.83%，平均跌幅为1.46%。该股近5个交易日上涨0.10%，主力资金累计净流入638万元，其中1个交易日为股价下跌时净流入；近20日主力资金累计净流出3880万元，其中净流出天数为15日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240726152032955c9e41&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240726152032955c9e41&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0010","BK0082","BK0028","BK0185","BK0188","600056","BK0250","BK0175"],"gpt_icon":0},{"id":"2453762707","title":"天眼查App显示近日中国医药集团有限公司发生工商变更刘敬桢卸任法定代表人、董事长由白忠泉接任同时多位主要人员也发生变更。中国医药集团有限公司成立于1987年3月注册资本约255.","url":"https://stock-news.laohu8.com/highlight/detail?id=2453762707","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2453762707?lang=zh_cn&edition=full","pubTime":"2024-07-23 16:27","pubTimestamp":1721723241,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK0028","BK0082","600056","BK0010","BK0175","BK0188","BK0185","BK0250"],"gpt_icon":0},{"id":"2453099788","title":"北向资金7月19日净买入中国医药7.46万股 连续3日增持","url":"https://stock-news.laohu8.com/highlight/detail?id=2453099788","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2453099788?lang=zh_cn&edition=full","pubTime":"2024-07-22 09:30","pubTimestamp":1721611807,"startTime":"0","endTime":"0","summary":"7月19日, 北向资金增持中国医药7.46万股，连续3日增持。截止当日收盘，沪股通共持有中国医药1609.07万股，占流通股1.07%。沪股通增持金额前五个股分别为XD江淮汽、赤峰黄金、中金黄金、北汽蓝谷、伊利股份。中国医药近5个交易日上涨0.10%，沪股通累计增持16.23万股；近20个交易日下跌2.31%，沪股通累计增持109.99万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407220930169edd4c1d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407220930169edd4c1d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["600056","BK0082","BK0028","BK0185","BK0010","BK0175","BK0250","BK0188"],"gpt_icon":0},{"id":"2452101166","title":"中国医药(600056.SH)：通用技术集团拟收购重庆医药相关股权","url":"https://stock-news.laohu8.com/highlight/detail?id=2452101166","media":"格隆汇资讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2452101166?lang=zh_cn&edition=full","pubTime":"2024-07-18 18:26","pubTimestamp":1721298397,"startTime":"0","endTime":"0","summary":"格隆汇7月18日丨中国医药(600056.SH)公布，2024年7月18日，公司收到通用技术集团转发的国家市场监督管理总局出具的《经营者集中反垄断审查不实施进一步审查决定书》(反执二审查决定〔2024〕346号)，具体内容如下：“根据《中华人民共和国反垄断法》第三十条规定，经初步审查，现决定，对中国通用技术(集团)控股有限责任公司收购重庆医药健康产业有限公司股权案不实施进一步审查。你公司从即日起可以实施集中。该案涉及经营者集中反垄断审查之外的其他事项，依据相关法律办理。”","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024071818271795d506f3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024071818271795d506f3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0082","BK0250","600056","BK0188","BK0010","BK0185","BK0175","BK0028"],"gpt_icon":0},{"id":"2451657000","title":"血液制品概念盘中跳水，同方股份跌1.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2451657000","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2451657000?lang=zh_cn&edition=full","pubTime":"2024-07-15 09:40","pubTimestamp":1721007601,"startTime":"0","endTime":"0","summary":"07月15日，血液制品概念盘中跳水，截至09点39分，血液制品概念整体指数下跌0.52%，报729.180点。从个股上来看，该概念的成分股中，同方股份跌1.00%，中国医药、君正集团、华兰生物跌幅居前。从资金上来看，截止发稿，血液制品概念概念主力净流入为70.86万，其中中国医药受到资金热捧，主力净流入204.04万；拉长时间线来看，该板块近20日主力资金净流入-6.82亿。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240715094001af92454e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240715094001af92454e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0196","600056","BK0175","600100","BK0026","BK0043","BK0185","BK0188","BK0038","BK0010","BK0250","BK0030","BK0012","BK0045","BK0067","BK0101","BK0214","BK0082","BK0041","BK0122","BK0028","BK0124"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"1997-05-15","address":"北京市丰台区西营街1号院1区1号楼25-28层","stockEarnings":[{"period":"1week","weight":-0.0188},{"period":"1month","weight":0.0418},{"period":"3month","weight":-0.0457},{"period":"6month","weight":-0.0516},{"period":"1year","weight":-0.2148},{"period":"ytd","weight":-0.044}],"companyName":"中国医药健康产业股份有限公司","boardCode":"AI0051","perCapita":"8882股","boardName":"批发业","registeredCapital":"149587万元","compareEarnings":[{"period":"1week","weight":0.0026},{"period":"1month","weight":-0.0332},{"period":"3month","weight":-0.0877},{"period":"6month","weight":0.004},{"period":"1year","weight":-0.0866},{"period":"ytd","weight":-0.0328}],"survey":" 中国医药健康产业股份有限公司建立了以国际贸易为引领、以医药工业为支撑、以医药商业为纽带的贸、工、技、服一体化产业格局，全面推动工商贸三大业务板块业务整合，积极发挥协同优势。主要产品有原料药、制剂药、中成药、医药商业、国际贸易。公司在中国物流与采购联合会医疗器械供应链分会发布的“2023年中国医疗器械供应链百强企业”中位列第5位；在“2023年中国医疗器械SPD运营服务商重点企业”中位列第11位。","serverTime":1723799162854,"listedPrice":7.02,"stockholders":"168356人(较上一季度减少5.38%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.26.2","shortVersion":"4.26.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"中国医药(600056)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供中国医药(600056)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"中国医药,600056,中国医药股票,中国医药股票老虎,中国医药股票老虎国际,中国医药行情,中国医药股票行情,中国医药股价,中国医药股市,中国医药股票价格,中国医药股票交易,中国医药股票购买,中国医药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"中国医药(600056)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供中国医药(600056)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}